Media headlines about RTI Surgical (NASDAQ:RTIX) have been trending positive on Friday, Alpha One reports. Alpha One, a subsidiary of Accern, scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.48 on Alpha One’s scale. Alpha One also assigned news headlines about the medical equipment provider an impact score of 37 out of 100, indicating that recent press coverage is unlikely to have an impact on the company’s share price in the next few days.
Several analysts have commented on the stock. TheStreet raised shares of RTI Surgical from a “d+” rating to a “c-” rating in a research report on Friday, May 5th. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th.
RTI Surgical (NASDAQ:RTIX) traded up 3.16% during mid-day trading on Friday, hitting $4.90. 175,576 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $4.20 and its 200-day moving average price is $3.52. The stock’s market cap is $284.82 million. RTI Surgical has a one year low of $2.50 and a one year high of $4.95.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, April 27th. The medical equipment provider reported ($0.05) EPS for the quarter. RTI Surgical had a return on equity of 4.60% and a net margin of 0.24%. The company had revenue of $69.90 million for the quarter, compared to analyst estimates of $67.68 million. During the same period in the prior year, the firm posted $0.03 earnings per share. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, analysts forecast that RTI Surgical will post $0.08 EPS for the current fiscal year.
In related news, Director Nicholas J. Valeriani acquired 5,500 shares of the stock in a transaction dated Thursday, May 4th. The stock was acquired at an average cost of $4.60 per share, with a total value of $25,300.00. Following the completion of the transaction, the director now owns 25,770 shares in the company, valued at approximately $118,542. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Jonathon M. Singer acquired 10,000 shares of the stock in a transaction dated Thursday, March 2nd. The shares were bought at an average cost of $3.79 per share, with a total value of $37,900.00. Following the completion of the transaction, the director now owns 30,270 shares of the company’s stock, valued at approximately $114,723.30. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 60,330 shares of company stock valued at $265,449. Corporate insiders own 6.10% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.